Dexamethasone for Preterm Labour
- Conditions
- Prematurity
- Interventions
- Registration Number
- NCT01697098
- Lead Sponsor
- Assiut University
- Brief Summary
The investigators sought to determine whether the incidence of neonatal respiratory distress syndrome (RDS) in preterm fetuses is similar with 12- vs 24-hour dosing interval of dexamethasone.
- Detailed Description
The administration of glucocorticoids to accelerate fetal lung maturity in patients with preterm delivery plays an important role for obstetrics and neonatal care. Many studies have shown that maternal administration of glucocorticoids has a significant beneficial effect in decreasing the incidence of respiratory distress syndrome (RDS) in infants delivered at 28-34 weeks of gestation.
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- Female
- Target Recruitment
- 200
- All patient with threatened or established preterm labor between 28 - 34 weeks attended to our emergency unit
-
emergent obstetric conditions like:
- Antepartum hemorrhage in severe attack
- Antepartum eclampsia
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Arm && Interventions
Group Intervention Description 12 hours Dexamethasone Dexamethasone 12 Those patient will be given 12 hours dexamethasone after randomization 24 hours Dexamethasone Dexamethasone 24 hours Those patient will be give 24 hours dexamethasone after randomization
- Primary Outcome Measures
Name Time Method respiratory distress syndrome (RDS) 6 month determine whether the incidence of neonatal respiratory distress syndrome (RDS) is similar with 12- vs 24-hour dosing interval of dexamethasone.
- Secondary Outcome Measures
Name Time Method Perinatal mortality 6 month Determine whether the incidence of perinatal mortality is similar with 12- vs 24-hour dosing interval of dexamethasone.
Trial Locations
- Locations (1)
Women Health Hospital - Assiut university
🇪🇬Assiut, Egypt